SARS-CoV-2-IN-124
SARS-CoV-2-IN-124 is an antiviral compound. SARS-CoV-2-IN-124 directly binds to NCOA1 and promotes its lysosome-dependent degradation. SARS-CoV-2-IN-124 downregulates the expression of lipogenic enzymes FASN and SCD1. SARS-CoV-2-IN-124 inhibits SARS-CoV-2 replication in multiple cell lines. SARS-CoV-2-IN-124 can be used for research related to SARS-CoV-2 infection.
For research use only. We do not sell to patients.
- CAS No.: 3093981-26-8
- Formula: C17H17Cl2NO2
- Molecular Weight:338.23
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Vero | EC50 |
0.9 μM
|
Inhibition of prototypic SARS-CoV-2 strain replication in Vero cells measured by quantifying viral RNA via RT-qPCR at 48 h post-infection.
Inhibition of prototypic SARS-CoV-2 strain replication in Vero cells measured by quantifying viral RNA via RT-qPCR at 48 h post-infection.
|
42603033 |
| Vero | EC50 |
0.5 μM
|
Inhibition of SARS-CoV-2 Omicron BA.1 variant replication in Vero cells measured by quantifying viral RNA via RT-qPCR at 48 h post-infection.
Inhibition of SARS-CoV-2 Omicron BA.1 variant replication in Vero cells measured by quantifying viral RNA via RT-qPCR at 48 h post-infection.
|
42603033 |
| Vero | CC50 |
44.1 μM
|
Cytotoxicity in Vero cells measured after 48 h of incubation.
Cytotoxicity in Vero cells measured after 48 h of incubation.
|
42603033 |
In Vitro
SARS-CoV-2-IN-124 (Compound 10) (0-20 μM) exhibits potent anti-SARS-CoV-2 activity against both the prototype strain and the BA.1 SARS-CoV-2 strain in Vero cells, with corresponding EC50 values of 0.9 μM and 0.5 μM respectively, and shows low associated cytotoxicity (CC50 = 44.1 μM)[1].
SARS-CoV-2-IN-124 (8 μM) completely inhibits the expression of the SARS-CoV-2 nucleocapsid protein in infected Vero cells[1].
SARS-CoV-2-IN-124 (8 μM; 24-48 h post-infection) significantly inhibits the viral RNA replication of SARS-CoV-2 in infected Huh-7 and Caco-2 cells at 24 h and 48 h post-infection[1].
SARS-CoV-2-IN-124 (2-8 μM; 48 h) downregulates the expression of lipogenic enzymes FASN and SCD1 in Huh-7 and Caco-2 cells in a dose-dependent manner under multiple infection conditions[1].
SARS-CoV-2-IN-124 (8 μM; 24 h) promotes the lysosome-dependent degradation of NCOA1 protein, while the proteasomal degradation pathway is not involved in this process[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Vero cells
-
Concentration:0-20 μM
-
Incubation Time:48 h post-infection
-
Result:Potently inhibited replication of the prototypic SARS-CoV-2 strain with an EC50 of 0.9 μM, and potently inhibited replication of the Omicron BA.1 variant with an EC50 of 0.5 μM.
Recorded a 50% cytotoxic concentration (CC50) of 44.1 μM in Vero cells.
-
Cell Line:Huh-7 and Caco-2 cells (uninfected or SARS-CoV-2 infected)
-
Concentration:2, 4, 8 μM
-
Incubation Time:48 h
-
Result:Caused a dose-dependent reduction in both FASN and SCD1 protein levels.
Exhibited this suppressive effect on FASN and SCD1 under both mock-infected conditions and infection with either prototypic SARS-CoV-2 or the Omicron BA.1 variant.
Chemical Information
-
CAS No. 3093981-26-8
-
Molecular Weight 338.23
-
Formula C17H17Cl2NO2
-
SMILES
OC1=C(NC(C2=CC(Cl)=CC(Cl)=C2)=O)C=C(C(C)(C)C)C=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)